Literature DB >> 15890709

No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population.

Begoña Diosdado1, Dariusz T Stepniak, Alienke J Monsuur, Lude Franke, Martin C Wapenaar, Maria Luisa Mearin, Frits Koning, Cisca Wijmenga.   

Abstract

Celiac disease (CD) is a complex genetic disorder of the small intestine. The DQ2/DQ8 human leucocyte antigen (HLA) genes explain approximately 40% of the genetic component of the disease, but the remaining non-HLA genes have not yet been identified. The key environmental factor known to be involved in the disease is gluten, a major protein present in wheat, barley, and rye. Integrating microarray data and linkage data from chromosome 6q21-22 revealed the prolyl endopeptidase (PREP) gene as a potential CD candidate in the Dutch population. Interestingly, this gene encodes for the only enzyme that is able to cleave the proline-rich gluten peptides. To investigate the role of the human PREP gene as a primary genetic factor in CD, we conducted gene expression, sequence analysis, and genetic association studies of the PREP gene and determined PREP enzyme activity in biopsies from CD patients and controls. Sequence analysis of the coding region of the PREP gene revealed two novel polymorphisms. Genetic association studies using two novel polymorphisms and three known PREP variants excluded a genetic association between PREP and CD. Determination of PREP activity revealed weak but significant differences between treated and untreated CD biopsies (P < 0.05). Our results from the association study indicate that PREP is not a causative gene for CD in the Dutch population. These are further supported by the activity determinations in which we observed no differences in PREP activity between CD patients and controls.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890709     DOI: 10.1152/ajpgi.00056.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  3 in total

1.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  Oral proteases: a new approach to managing coeliac disease.

Authors:  Nadine Cerf-Bensussan; Tamara Matysiak-Budnik; Christophe Cellier; Martine Heyman
Journal:  Gut       Date:  2006-09-01       Impact factor: 23.059

3.  Multiple independent variants in 6q21-22 associated with susceptibility to celiac disease in the Dutch, Finnish and Hungarian populations.

Authors:  Elisabet Einarsdottir; Marianna R Bevova; Alexandra Zhernakova; Alienke Monsuur; Lotta L E Koskinen; Ruben van't Slot; Chris Mulder; M Luisa Mearin; Ilma R Korponay-Szabo; Katri Kaukinen; Kalle Kurppa; Juha Kere; Markku Mäki; Cisca Wijmenga; Päivi Saavalainen
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.